Related references
Note: Only part of the references are listed.Association Between Vomiting and QT Hysteresis: Data from a TQT Study with the Endothelin A Receptor Antagonist Clazosentan
Pierre-Eric Juif et al.
AAPS JOURNAL (2020)
Models of Variability and Circadian Rhythm in Heart Rate, Blood Pressure, and QT Interval for Healthy Subjects Who Received Placebo in Phase I Trials
Mukul Minocha et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)
Scientific white paper on concentration-QTc modeling
Christine Garnett et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2018)
Importance of QT/RR hysteresis correction in studies of drug-induced QTc interval changes
Marek Malik et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2018)
Operational Characteristics of Linear Concentration-QT Models for Assessing QTc Interval in the Thorough QT and Phase I Clinical Studies
C. Garnett et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Universal Correction for QT/RR Hysteresis
Marek Malik et al.
DRUG SAFETY (2016)
Enhanced Method for Diagnosing Pharmacometric Models: Random Sampling from Conditional Distributions
Marc Lavielle et al.
PHARMACEUTICAL RESEARCH (2016)
Modeling and Simulation Approaches for Cardiovascular Function and Their Role in Safety Assessment
T. A. Collins et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2015)
Challenges in collecting pharmacokinetic and pharmacodynamic information in an intensive care setting: PK/PD modelling of clazosentan in patients with aneurysmal subarachnoid haemorrhage
Jochen Zisowsky et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
QT interval measurement and correction in patients with atrial flutter: a pilot study
V. Jacquemet et al.
JOURNAL OF ELECTROCARDIOLOGY (2014)
QT/RR hysteresis
Marek Malik
JOURNAL OF ELECTROCARDIOLOGY (2014)
Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics
Hoai-Thu Thai et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2014)
DELAYED EFFECTS IN THE EXPOSURE-RESPONSE ANALYSIS OF CLINICAL QTc TRIALS
Patricia Glomb et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2012)
In vitro and in vivo pharmacokinetic characteristics of clazosentan, an intravenous endothelin receptor antagonist, in humans
P.L.M. van Giersbergen et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Subject-specific profiles of QT/RR hysteresis
Marek Malik et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Tolerability, pharmacokinetics, and pharmacodynamics of clazosentan, a parenteral endothelin receptor antagonist
Paul L. M. van Giersbergen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Cardiac tolerance of moxifloxacin: clinical experience from a large observational French study in usual medical practice (IMMEDIAT study)
P. Veyssier et al.
MEDECINE ET MALADIES INFECTIEUSES (2006)
Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation
V Piotrovsky
AAPS JOURNAL (2005)
Drug-induced Torsades de Pointes and implications for drug development
RR Fenichel et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2004)